| Code | Description | Billable |
|---|---|---|
| Z79.0 | Long term (current) use of anticoagulants and antithrombotics/antiplatelets Excludes2
| Header |
| Z79.01 | Long term (current) use of anticoagulants | Billable |
| Z79.02 | Long term (current) use of antithrombotics/antiplatelets | Billable |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) Excludes2
| Billable |
| Z79.2 | Long term (current) use of antibiotics | Billable |
| Z79.3 | Long term (current) use of hormonal contraceptives Includes
| Billable |
| Z79.4 | Long term (current) use of insulin Excludes2
| Billable |
| Z79.5 | Long term (current) use of steroids | Header |
| Z79.51 | Long term (current) use of inhaled steroids | Billable |
| Z79.52 | Long term (current) use of systemic steroids | Billable |
| Z79.6 | Long term (current) use of immunomodulators and immunosuppressants Excludes2
| Header |
| Z79.60 | Long term (current) use of unspecified immunomodulators and immunosuppressants | Billable |
| Z79.61 | Long term (current) use of immunomodulator Includes
| Billable |
| Z79.62 | Long term (current) use of immunosuppressant | Header |
| Z79.620 | Long term (current) use of immunosuppressive biologic Includes
| Billable |
| Z79.621 | Long term (current) use of calcineurin inhibitor Includes
| Billable |
| Z79.622 | Long term (current) use of Janus kinase inhibitor Includes
| Billable |
| Z79.623 | Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor Includes
| Billable |
| Z79.624 | Long term (current) use of inhibitors of nucleotide synthesis Includes
| Billable |
| Z79.63 | Long term (current) use of chemotherapeutic agent | Header |
| Z79.630 | Long term (current) use of alkylating agent Includes
| Billable |
| Z79.631 | Long term (current) use of antimetabolite agent Includes
| Billable |
| Z79.632 | Long term (current) use of antitumor antibiotic Includes
| Billable |
| Z79.633 | Long term (current) use of mitotic inhibitor Includes
| Billable |
| Z79.634 | Long term (current) use of topoisomerase inhibitor Includes
| Billable |
| Z79.64 | Long term (current) use of myelosuppressive agent Includes
| Billable |
| Z79.69 | Long term (current) use of other immunomodulators and immunosuppressants | Billable |
| Z79.8 | Other long term (current) drug therapy | Header |
| Z79.81 | Long term (current) use of agents affecting estrogen receptors and estrogen levels Excludes1
Code first
Use additional code
| Header |
| Z79.810 | Long term (current) use of selective estrogen receptor modulators (SERMs) Includes
| Billable |
| Z79.811 | Long term (current) use of aromatase inhibitors Includes
| Billable |
| Z79.818 | Long term (current) use of other agents affecting estrogen receptors and estrogen levels Includes
| Billable |
| Z79.82 | Long term (current) use of aspirin | Billable |
| Z79.83 | Long term (current) use of bisphosphonates | Billable |
| Z79.84 | Long term (current) use of oral hypoglycemic drugs Includes
Excludes2
| Billable |
| Z79.85 | Long-term (current) use of injectable non-insulin antidiabetic drugs Excludes2
| Billable |
| Z79.89 | Other long term (current) drug therapy | Header |
| Z79.890 | Hormone replacement therapy | Billable |
| Z79.891 | Long term (current) use of opiate analgesic Includes
Excludes1
| Billable |
| Z79.899 | Other long term (current) drug therapy | Billable |
From the ICD-10-CM FY2026 tabular list published by CDC’s National Center for Health Statistics (a US government work, free to reuse). Check the release in force before you code a claim. The source file